Spero Therapeutics (SPRO) Current Assets (2016 - 2026)
Spero Therapeutics (SPRO) recorded Current Assets of $51.58 million in Q2 2026, down 13.2% from $59.4 million a year earlier and down 10.5% from the prior quarter.
Spero Therapeutics (SPRO) Current Assets (2016 - 2026) Analysis & Trends
At the end of FY2025, Spero Therapeutics reported Current Assets of $67.29 million, down 37.3% from FY2024.
- Annual Current Assets has a five-year compound annual growth rate of -13.5% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $107.28 million in FY2024 (-18.2%), $131.21 million in FY2023 (+15.5%), $113.57 million in FY2022 (-28.1%) and $157.87 million in FY2021 (+13.5%).
- The Q2 2026 figure is the lowest quarterly Current Assets since Q3 2017.
- On a year-over-year basis, Current Assets has declined for seven consecutive quarters, with an average decline of 27.6% over the last eight quarters.
- Peak year-over-year performance for Current Assets in the last five years was growth of 93.3% in Q3 2023, against a decline of 60.2% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $57.61 million (Q1 2026), $67.29 million (Q4 2025) and $52.32 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Spero Therapeutics | 68.40 Mn | -127.38 Mn | - | 51.58 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.58 Mn |
| Mar 31, 2026 | 57.61 Mn |
| Dec 31, 2025 | 67.29 Mn |
| Sep 30, 2025 | 52.32 Mn |
| Jun 30, 2025 | 59.40 Mn |
| Mar 31, 2025 | 74.71 Mn |
| Dec 31, 2024 | 107.28 Mn |
| Sep 30, 2024 | 131.63 Mn |
| Jun 30, 2024 | 122.22 Mn |
| Mar 31, 2024 | 140.15 Mn |
| Dec 31, 2023 | 131.21 Mn |
| Sep 30, 2023 | 102.22 Mn |
| Jun 30, 2023 | 88.35 Mn |
| Mar 31, 2023 | 101.66 Mn |
| Dec 31, 2022 | 113.57 Mn |
| Sep 30, 2022 | 52.89 Mn |
| Jun 30, 2022 | 51.95 Mn |
| Mar 31, 2022 | 132.70 Mn |
| Dec 31, 2021 | 157.87 Mn |
| Sep 30, 2021 | 131.77 Mn |
Spero Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=SPRO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();